Belgium's UCB to buy Ra Pharmaceuticals in $2.1 bln cash deal
Oct 10 (Reuters) - UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for $2.1 billion, both companies reported on Thursday, in a deal that will...
Oct 10 (Reuters) - UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for $2.1 billion, both companies reported on Thursday, in a deal that will...